Hims & Hers Health, Inc. is an innovative telehealth company that uses AI-driven processes and comprehensive patient data to create a competitive advantage difficult for others to replicate. Its vertical integration and scale further strengthen its market position. Management anticipates growth acceleration in the latter part of 2026 and maintains an ambitious target for 2030, positioning Hims as a notable disruptor in the healthcare industry beyond traditional models.
The Federal Trade Commission (FTC) is suing healthcare company Hims & Hers for allegedly sharing customers' sensitive medical data with advertisers and tech giants like Meta and Snap without consent. The FTC claims Hims & Hers used pixel trackers to ...
Wall Street experienced a significant selloff with the Nasdaq 100 nearing correction territory and the Dow Jones dropping over 1,000 points, wiping out recent gains. The selloff is driven by fears of rising interest rates after three Federal Reserve ...
The Federal Trade Commission (FTC) has filed a lawsuit against Hims & Hers Health, Inc., alleging the company misled consumers by charging for prescriptions immediately after intake forms were submitted, despite promising consultations to find suitab...
The U.S. Federal Trade Commission (FTC) has sued telehealth company Hims & Hers for allegedly sharing users' sensitive health data with advertisers like Meta and Snap, despite promising privacy. The FTC also accused the company of deceptive billing, ...
The Federal Trade Commission sued telehealth company Hims & Hers, accusing it of improperly sharing sensitive user health data with advertisers like Meta and Snap without consent. The FTC also alleges the company charged customers for prescriptions b...
